Literature DB >> 23559908

Cucurbitacins - a promising target for cancer therapy.

Abdullah A Alghasham1.   

Abstract

During the last decades a large number of cucurbitacins have been isolated from various plant species belonging to other plant families than Cucurbitaceae. Although the roots and the fruits of plant belong to these Cucurbitaceae species are very bitter, they have been used as folk medicines in some countries because of their wide spectrum of pharmacological activities such as anti-inflammation and anticancer effects. In the last ten years, cucurbitacins had been shown to inhibit proliferation and induced apoptosis utilizing a long array of in vitro and in vivo cancer cell models. Several molecular targets for cucurbitacins have been discovered, such as fibrous-actin, signal transducer and activator of transcription (STAT), cyclooxygenase-2, etc. This review aimed at elucidating the natural sources of some cucurbitacin compounds, their chemical structure and derivatives, physical properties, biological activities and mechanism by which they reduce the proliferation human cancer cells. This widens our armaments against a devastating disease that we are failing to face.

Entities:  

Keywords:  Cucurbitacin; Janus kinase (JAK); STAT; anti-inflammation; anti-tumor; apoptosis

Year:  2013        PMID: 23559908      PMCID: PMC3612419          DOI: 10.12816/0006025

Source DB:  PubMed          Journal:  Int J Health Sci (Qassim)        ISSN: 1658-3639


  74 in total

Review 1.  Cucurbitacins as inducers of cell death and a rich source of potential anticancer compounds.

Authors:  J L Ríos; I Andújar; J M Escandell; R M Giner; M C Recio
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  In vitro and in vivo study of cucurbitacins-type triterpene glucoside from Citrullus colocynthis growing in Saudi Arabia against hepatocellular carcinoma.

Authors:  Seif-Eldin N Ayyad; Ahmed Abdel-Lateff; Walied M Alarif; Francesca R Patacchioli; Farid A Badria; Saleh T Ezmirly
Journal:  Environ Toxicol Pharmacol       Date:  2011-12-16       Impact factor: 4.860

3.  Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.

Authors:  R Garcia; T L Bowman; G Niu; H Yu; S Minton; C A Muro-Cacho; C E Cox; R Falcone; R Fairclough; S Parsons; A Laudano; A Gazit; A Levitzki; A Kraker; R Jove
Journal:  Oncogene       Date:  2001-05-03       Impact factor: 9.867

4.  Isolation, structure elucidation, and biological evaluation of 16,23-epoxycucurbitacin constituents from Eleaocarpus chinensis.

Authors:  Li Pan; Yeonjoong Yong; Ye Deng; Daniel D Lantvit; Tran Ngoc Ninh; Heebyung Chai; Esperanza J Carcache de Blanco; Djaja D Soejarto; Steven M Swanson; A Douglas Kinghorn
Journal:  J Nat Prod       Date:  2012-01-12       Impact factor: 4.050

5.  Dihydrocucurbitacin B, isolated from Cayaponia tayuya, reduces damage in adjuvant-induced arthritis.

Authors:  José Miguel Escandell; María-Carmen Recio; Salvador Máñez; Rosa-María Giner; Miguel Cerdá-Nicolás; José-Luis Ríos
Journal:  Eur J Pharmacol       Date:  2006-01-27       Impact factor: 4.432

6.  Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors.

Authors:  N Stahl; T J Farruggella; T G Boulton; Z Zhong; J E Darnell; G D Yancopoulos
Journal:  Science       Date:  1995-03-03       Impact factor: 47.728

7.  Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.

Authors:  Michelle A Blaskovich; Jiazhi Sun; Alan Cantor; James Turkson; Richard Jove; Saïd M Sebti
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

8.  Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?

Authors:  H J Andreyev; A R Norman; J Oates; D Cunningham
Journal:  Eur J Cancer       Date:  1998-03       Impact factor: 9.162

9.  Anti-inflammatory activity of two cucurbitacins isolated from Cayaponia tayuya roots.

Authors:  M Carmen Recio; Maite Prieto; Marina Bonucelli; Cecilia Orsi; Salvador Máñez; Rosa M Giner; M Cerdá-Nicolás; José-Luis Ríos
Journal:  Planta Med       Date:  2004-05       Impact factor: 3.352

Review 10.  Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution.

Authors:  Bharat B Aggarwal; Gautam Sethi; Kwang Seok Ahn; Santosh K Sandur; Manoj K Pandey; Ajaikumar B Kunnumakkara; Bokyung Sung; Haruyo Ichikawa
Journal:  Ann N Y Acad Sci       Date:  2006-12       Impact factor: 5.691

View more
  23 in total

1.  JAK-STAT signaling regulation of chicken embryonic stem cell differentiation into male germ cells.

Authors:  Yu Zhang; Lei Zhang; Qisheng Zuo; Yinjie Wang; Yani Zhang; Qi Xu; Bichun Li; Guohong Chen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-06-08       Impact factor: 2.416

2.  Cytotoxic effects of natural and semisynthetic cucurbitacins on lung cancer cell line A549.

Authors:  Izabella Thaís Silva; Fabiana Cristina Geller; Lara Persich; Sabine Eva Dudek; Karen Luise Lang; Miguel Soriano Balparda Caro; Fernando Javier Durán; Eloir Paulo Schenkel; Stephan Ludwig; Cláudia Maria Oliveira Simões
Journal:  Invest New Drugs       Date:  2016-01-16       Impact factor: 3.850

3.  Growth inhibitory effect of Cucurbitacin E on breast cancer cells.

Authors:  Tian Lan; Linling Wang; Qian Xu; Weiguo Liu; Hongchuan Jin; Weimin Mao; Xian Wang; Xiaojia Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

Review 4.  Triterpenes in cancer: significance and their influence.

Authors:  Balraj Singh Gill; Sanjeev Kumar
Journal:  Mol Biol Rep       Date:  2016-06-25       Impact factor: 2.316

5.  Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B.

Authors:  Fardous F El-Senduny; Farid A Badria; Ahmed M El-Waseef; Subhash C Chauhan; Fathi Halaweish
Journal:  Tumour Biol       Date:  2015-08-05

6.  In vitro and in vivo antitumor activity of a novel semisynthetic derivative of cucurbitacin B.

Authors:  Izabella T Silva; Annelise Carvalho; Karen L Lang; Sabine E Dudek; Dörthe Masemann; Fernando J Durán; Miguel S B Caro; Ulf R Rapp; Viktor Wixler; Eloir P Schenkel; Cláudia M O Simões; Stephan Ludwig
Journal:  PLoS One       Date:  2015-02-12       Impact factor: 3.240

7.  Therapeutic ROS targeting of GADD45γ in the induction of G2/M arrest in primary human colorectal cancer cell lines by cucurbitacin E.

Authors:  Y-C Hsu; T-Y Huang; M-J Chen
Journal:  Cell Death Dis       Date:  2014-04-24       Impact factor: 8.469

8.  HPTLC Analysis of Bioactivity Guided Anticancer Enriched Fraction of Hydroalcoholic Extract of Picrorhiza kurroa.

Authors:  Md Nasar Mallick; Mhaveer Singh; Rabea Parveen; Washim Khan; Sayeed Ahmad; Mohammad Zeeshan Najm; Syed Akhtar Husain
Journal:  Biomed Res Int       Date:  2015-10-18       Impact factor: 3.411

9.  Cucurbitacin covalent bonding to cysteine thiols: the filamentous-actin severing protein Cofilin1 as an exemplary target.

Authors:  Mads Gabrielsen; Maike Schuldt; June Munro; Dagmara Borucka; Jenifer Cameron; Mark Baugh; Andrzej Mleczak; Sergio Lilla; Nicholas Morrice; Michael F Olson
Journal:  Cell Commun Signal       Date:  2013-08-14       Impact factor: 5.712

10.  Inducement of mitosis delay by cucurbitacin E, a novel tetracyclic triterpene from climbing stem of Cucumis melo L., through GADD45γ in human brain malignant glioma (GBM) 8401 cells.

Authors:  Y-C Hsu; M-J Chen; T-Y Huang
Journal:  Cell Death Dis       Date:  2014-02-27       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.